ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Capital expenditures 2016–2025
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$22.7MFY2025 · since FY2016: $3.9M → $22.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $22.7M | -84.0% |
| FY2024 | $141.5M | -20.0% |
| FY2023 | $176.7M | +234.9% |
| FY2022 | $52.8M | +123.9% |
| FY2021 | $23.6M | +97.2% |
| FY2020 | $12.0M | -0.4% |
| FY2019 | $12.0M | +744.4% |
| FY2018 | $1.4M | -82.1% |
| FY2017 | $7.9M | +105.1% |
| FY2016 | $3.9M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice